Plain-English translation of NCT06915454 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a special imaging technique called high-resolution PET-CT can help surgeons see the exact edges of tumors during cancer surgery. Before your surgery, you'll receive a very small dose of a tracer called 18F-FDG through an IV. After your tumor is removed, the surgical specimen will be scanned with a special imaging machine to see if this technique can clearly show where the cancer ends and healthy tissue begins.
During cancer surgery, it's very important for surgeons to remove all the cancer while protecting as much healthy tissue as possible. This trial is exploring whether this new imaging approach can give surgeons better real-time information about where tumor edges are, which could improve surgery outcomes and reduce the need for repeat surgeries.
You likely qualify if…
You likely don't qualify if…
On the day of your surgery, you will receive a small IV injection of the tracer medication just before your surgical procedure begins. After your surgeon removes the tumor, the tissue will be scanned using a special imaging machine called the XEOS Aura PET/CT device. The entire study involves this single procedure during your scheduled cancer surgery—there are no additional follow-up visits required for the research portion.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
United States